What is LOPJLB’s current signal on INVA?

LOPJLB’s latest quantitative signal on Innoviva, Inc. (INVA) is BUY in a RECOVERY regime. Signals are updated daily.

What market regime is INVA in?

Innoviva, Inc. (INVA) is currently classified in the RECOVERY HMM market regime on LOPJLB.

What does Innoviva, Inc. (INVA) do?

Innoviva, Inc. functions as a pharmaceutical company, concentrating on the worldwide creation and marketing of medical treatments. Its current product lineup prominently includes several once-daily combination therapies: RELVAR/BREO ELLIPTA, which integrates vilanterol (a long-acting beta2 agonist, or LABA) with fluticasone furoate (an inhaled corticosteroid, or ICS); ANORO ELLIPTA, a medicatio…

Where is Innoviva, Inc. based / listed?

Innoviva, Inc. is based in US, listed on NASDAQ.

Innoviva, Inc. (INVA)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$21.21+1.63%Close

BUYRECOVERY · day 8

RANGE

DATA 2026-10-09

LOPJLB.COM

OHLCEMALEVELSSTOPFLIP52WSIGNALSBUYSELLEXHEXH ZONE

Key stats

Short interest · FINRA settlement 2026-09-30

Market cap: $1.6B
Beta: 0.33
P/E (TTM): 4.28

Short % float: 9.89%
Days to cover: 5.7
SI change: -4.2%

1W: +3.46%
1M: +2.86%

vs SPY 1W: +2.30%
vs SPY 1M: -0.13%

Industry peers

FMP comparable companies · ranked by market cap

TBPHBUYTheravance Biopharma Inc$883MBULLQ -1$17.03+0.00%

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Key stats

Industry peers

Prediction markets

Company news